• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Validation of measurement scores for evaluating vascular anomaly skin lesions.评估血管性畸形皮肤病变的测量评分的验证。
J Dermatol. 2021 Jul;48(7):993-998. doi: 10.1111/1346-8138.15839. Epub 2021 Mar 30.
2
Evaluation and management of peripheral venous and lymphatic malformations.周围静脉和淋巴管畸形的评估和管理。
J Vasc Surg Venous Lymphat Disord. 2016 Apr;4(2):257-65. doi: 10.1016/j.jvsv.2015.09.001. Epub 2016 Jan 12.
3
The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.西罗莫司治疗对淋巴管畸形患者病变大小、临床症状和生活质量的影响。
Orphanet J Rare Dis. 2019 Jun 13;14(1):141. doi: 10.1186/s13023-019-1118-1.
4
Fluctuating nature of an orbital venous-lymphatic anomaly in association with intracranial vascular malformations: a classical presentation.眶部静脉-淋巴管畸形与颅内血管畸形相关的波动特性:一种典型表现。
BMJ Case Rep. 2015 Oct 5;2015:bcr2015211573. doi: 10.1136/bcr-2015-211573.
5
Peripheral Vascular Anomalies - Essentials in Periinterventional Imaging.外周血管异常——介入治疗围手术期影像要点
Rofo. 2020 Feb;192(2):150-162. doi: 10.1055/a-0998-4300. Epub 2019 Oct 17.
6
The discriminative role of PROX-1 immunohistochemistry between venous malformation and lymphatic malformation of the deep type with no visible diagnostic surface skin lesion.PROX-1 免疫组化在无可见诊断性皮肤病变的深部静脉畸形和淋巴管畸形中的鉴别作用。
J Cutan Pathol. 2024 May;51(5):353-359. doi: 10.1111/cup.14569. Epub 2024 Jan 10.
7
Erythematous capillary-lymphatic malformations mimicking blood vascular anomalies.红斑毛细血管淋巴管畸形,类似血管性畸形。
JCI Insight. 2023 Oct 23;8(20):e172179. doi: 10.1172/jci.insight.172179.
8
Vascular malformations of the orbit (lymphatic, venous, arteriovenous): Diagnosis, management and results.眼眶脉管畸形(淋巴管性、静脉性、动静脉性):诊断、处理和结果。
J Craniomaxillofac Surg. 2019 May;47(5):726-740. doi: 10.1016/j.jcms.2018.09.009. Epub 2018 Sep 20.
9
[Venous malformations: clinical characteristics and differential diagnosis].[静脉畸形:临床特征与鉴别诊断]
Ann Chir Plast Esthet. 2006 Aug-Oct;51(4-5):373-87. doi: 10.1016/j.anplas.2006.07.018. Epub 2006 Sep 27.
10
Vascular malformations.血管畸形。
Pediatr Clin North Am. 2010 Oct;57(5):1091-110. doi: 10.1016/j.pcl.2010.08.003.

引用本文的文献

1
Upper Vascular Thoracic Outlet Syndrome: A Case Study.上肢血管性胸廓出口综合征:病例报告
Biomedicines. 2024 Aug 12;12(8):1829. doi: 10.3390/biomedicines12081829.

本文引用的文献

1
Newcomers in Vascular Anomalies.血管异常新进展。
Surg Pathol Clin. 2020 Dec;13(4):719-728. doi: 10.1016/j.path.2020.08.008.
2
Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.局部用西罗莫司 0.1%治疗儿童和成人皮肤微囊性淋巴管畸形(TOPICAL):一项多中心、个体内、随机、双盲、对照临床试验方案。
Trials. 2019 Dec 17;20(1):739. doi: 10.1186/s13063-019-3767-8.
3
Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.西罗莫司治疗血管异常的疗效和安全性:系统评价。
J Vasc Surg. 2020 Jan;71(1):318-327. doi: 10.1016/j.jvs.2019.06.217. Epub 2019 Oct 30.
4
The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.西罗莫司治疗对淋巴管畸形患者病变大小、临床症状和生活质量的影响。
Orphanet J Rare Dis. 2019 Jun 13;14(1):141. doi: 10.1186/s13023-019-1118-1.
5
Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.西罗莫司治疗巨大复杂浅表性慢血流血管畸形(PERFORMUS):一项采用随机观察阶段设计的多中心2期试验方案
Trials. 2018 Jun 27;19(1):340. doi: 10.1186/s13063-018-2725-1.
6
Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.西罗莫司凝胶治疗与安慰剂治疗结节性硬化症患者面部血管纤维瘤:一项随机临床试验。
JAMA Dermatol. 2018 Jul 1;154(7):781-788. doi: 10.1001/jamadermatol.2018.1408.
7
Efficacy and safety of oral propranolol for infantile hemangioma in Japan.口服普萘洛尔治疗日本婴幼儿血管瘤的疗效与安全性。
Pediatr Int. 2017 Aug;59(8):869-877. doi: 10.1111/ped.13318. Epub 2017 Jun 30.
8
Sirolimus in the Treatment of Vascular Anomalies.西罗莫司在血管异常治疗中的应用
Eur J Pediatr Surg. 2017 Feb;27(1):86-90. doi: 10.1055/s-0036-1593383. Epub 2016 Oct 10.
9
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.西罗莫司治疗复杂血管异常的疗效与安全性。
Pediatrics. 2016 Feb;137(2):e20153257. doi: 10.1542/peds.2015-3257. Epub 2016 Jan 18.
10
Using the Physician Global Assessment in a clinical setting to measure and track patient outcomes.在临床环境中使用医师总体评估来衡量和跟踪患者的结果。
JAMA Dermatol. 2015 Apr;151(4):375-81. doi: 10.1001/jamadermatol.2014.3513.

评估血管性畸形皮肤病变的测量评分的验证。

Validation of measurement scores for evaluating vascular anomaly skin lesions.

机构信息

Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.

Innovative and Clinical Research Promotion Center, Graduate School of Medicine, Gifu University, Gifu, Japan.

出版信息

J Dermatol. 2021 Jul;48(7):993-998. doi: 10.1111/1346-8138.15839. Epub 2021 Mar 30.

DOI:10.1111/1346-8138.15839
PMID:33786853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8360112/
Abstract

Vascular anomalies comprise a heterogeneous group of disorders caused by abnormal proliferation or development of vascular and/or lymphatic vessels. Vascular anomalies present with various symptoms and complications, but no standardized methods evaluate their severity, and to measure treatment outcomes is difficult. To assess the responsiveness of measurement scores for evaluating vascular anomaly skin lesions, we conducted a validation study to compare these measurement scores with patients' objective data. In this study, data were collected from treated and untreated patients. Skin lesions were photographed at baseline and after a follow-up period of 3-6 months. The volume of skin lesions, the degree of red or purple coloration, and color tone were measured objectively. Two external dermatologists evaluated patients' photographs and determined scores, which represented criteria for improvements in skin lesions (size and color) and 6-point Physician Global Assessment scores. The correlation between these scores and patients' objective data (lesion volume and color) was assessed to validate the scores. Twenty-three cases of vascular anomaly (seven vascular tumors, five lymphatic malformations, three venous malformations, and eight lymphatic-venous malformations) were examined. Scores for improvements in vascular anomaly skin lesions (size and color) correlated with a change in lesion volume, the degree of red or purple coloration, color tone score, and 6-point Physician Global Assessment score. Our findings suggest that these measurement scores are responsive to changes in vascular anomaly skin lesions after observation.

摘要

血管异常是一组由血管和/或淋巴管异常增殖或发育引起的异质性疾病。血管异常表现出各种症状和并发症,但没有标准化的方法来评估其严重程度,并且难以衡量治疗效果。为了评估测量评分评估血管异常皮肤病变的反应能力,我们进行了一项验证研究,将这些测量评分与患者的客观数据进行比较。在这项研究中,从接受治疗和未接受治疗的患者中收集数据。在基线和 3-6 个月的随访期间拍摄皮肤病变的照片。客观测量皮肤病变的体积、红色或紫色着色程度和色调。两位外部皮肤科医生评估患者的照片并确定评分,这些评分代表皮肤病变(大小和颜色)和 6 分医生整体评估评分改善的标准。评估这些评分与患者客观数据(病变体积和颜色)之间的相关性,以验证评分。检查了 23 例血管异常(七种血管肿瘤、五种淋巴管畸形、三种静脉畸形和八种淋巴静脉畸形)。血管异常皮肤病变(大小和颜色)改善的评分与病变体积变化、红色或紫色着色程度、色调评分和 6 分医生整体评估评分相关。我们的发现表明,这些测量评分对观察后血管异常皮肤病变的变化具有反应能力。